Short Interest in P3 Health Partners Inc. (NASDAQ:PIII) Grows By 32.8%

by · The Cerbat Gem

P3 Health Partners Inc. (NASDAQ:PIII – Get Free Report) was the recipient of a large increase in short interest in December. As of December 31st, there was short interest totaling 24,688 shares, an increase of 32.8% from the December 15th total of 18,589 shares. Based on an average trading volume of 16,172 shares, the days-to-cover ratio is presently 1.5 days. Approximately 0.4% of the company’s stock are short sold. Approximately 0.4% of the company’s stock are short sold. Based on an average trading volume of 16,172 shares, the days-to-cover ratio is presently 1.5 days.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the stock. BTIG Research reissued a “neutral” rating on shares of P3 Health Partners in a research report on Friday, December 12th. Weiss Ratings reiterated a “sell (e+)” rating on shares of P3 Health Partners in a research note on Wednesday, October 8th. Finally, Lake Street Capital cut their target price on P3 Health Partners from $20.00 to $12.50 and set a “buy” rating on the stock in a research note on Monday, November 17th. One investment analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $12.50.

Read Our Latest Stock Analysis on P3 Health Partners

Institutional Inflows and Outflows

A hedge fund recently raised its stake in P3 Health Partners stock. Trinity Financial Advisors LLC increased its position in P3 Health Partners Inc. (NASDAQ:PIII – Free Report) by 4.6% in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 26,678 shares of the company’s stock after acquiring an additional 1,178 shares during the quarter. Trinity Financial Advisors LLC owned about 0.37% of P3 Health Partners worth $239,000 as of its most recent SEC filing. 7.75% of the stock is currently owned by hedge funds and other institutional investors.

P3 Health Partners Stock Performance

PIII stock traded down $0.10 during mid-day trading on Friday, hitting $3.20. The company had a trading volume of 34,064 shares, compared to its average volume of 13,804. The company has a debt-to-equity ratio of 2.29, a quick ratio of 0.32 and a current ratio of 0.32. The firm has a market cap of $23.06 million, a PE ratio of -0.08 and a beta of 0.90. P3 Health Partners has a 12 month low of $2.87 and a 12 month high of $12.44. The stock’s fifty day moving average price is $4.77 and its two-hundred day moving average price is $6.81.

P3 Health Partners (NASDAQ:PIII – Get Free Report) last released its earnings results on Thursday, November 13th. The company reported ($9.67) earnings per share for the quarter, missing analysts’ consensus estimates of ($8.70) by ($0.97). The company had revenue of $345.25 million for the quarter, compared to the consensus estimate of $346.64 million. P3 Health Partners had a negative net margin of 9.07% and a negative return on equity of 302.33%. On average, analysts forecast that P3 Health Partners will post -0.67 earnings per share for the current fiscal year.

P3 Health Partners Company Profile

(Get Free Report)

P3 Health Partners is a healthcare technology and services company that delivers data-driven solutions to support health plans in improving quality measures, risk adjustment accuracy and operational efficiency. The company’s platform integrates advanced analytics, reporting capabilities and workflow automation to help clients optimize performance across value-based care programs and regulatory requirements.

The company’s core offerings include quality measurement and reporting for HEDIS, STAR and other performance frameworks, risk adjustment coding and audit services, and population health analytics.

Read More